x

Search for a clinical trial

* (*) mandatory field

CREATE (EORTC-90101): Cross-tumoral Phase 2 clinical trial exploring Crizotinib (PF-02341066) in patients with advanced tumor induced by causal alterations of ALK and/or MET - BE

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : Yes
  • Status : Ongoing trial
  • Funded by an IRDiRC member
  • Funding body(ies) :
  • Geographic coverage : European
  • Sponsor : Eortc
  • Website
  • Principal investigator of clinical trial

  • Dr Patrick SCHOFFSKI
  • Department of General Medical Oncology
  • University Hospitals Leuven - Gasthuisberg
  • Herestraat 49
  • 3000 LEUVEN
  • BELGIUM
  • More information
  • Phone  : +32 16 34 66 70
  • Fax  : -
  • Website
  • Sponsor of clinical trial

  • EORTC
  • European Organisation for the Research and Treatment of Cancer
  • EORTC
  • Avenue Mounierlaan 83/11
  • 1200 BRUSSELS
  • BELGIUM
  • More information
  • Phone  : 0032 2 7741611
  • Fax  : 0032 2 7723545
  • Website
Last update: July 2017

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.